Publication:
Efficacy and Persistence Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation

Simple item page
dc.authorwosidKuhle, Jens/Age-3474-2022
dc.authorwosidHorakova, Dana/D-4649-2011
dc.authorwosidVan Pesch, Vincent/Aak-9506-2020
dc.authorwosidMerlo, Daniel/Aan-2499-2021
dc.authorwosidKermode, Allan/G-3568-2019
dc.authorwosidTerzi̇, Murat/Aaa-1284-2021
dc.authorwosidPatti, Francesco/C-3300-2011
dc.contributor.authorZhu, C.
dc.contributor.authorKalincik, T.
dc.contributor.authorHorakova, D.
dc.contributor.authorZhen, Z.
dc.contributor.authorBuzzard, K.
dc.contributor.authorSkibina, O.
dc.contributor.authorButzkueven, H.
dc.contributor.authorIDKermode, Allan/0000-0002-4476-4016
dc.date.accessioned2025-12-11T01:04:04Z
dc.date.issued2022
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Zhu, C.; Buzzard, K.; Skibina, O.; Jokubaitis, V.; Monif, M.; Merlo, D.; Van der Walt, A.; Butzkueven, H.] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia; [Kalincik, T.] Univ Melbourne, Dept Neurosci, Melbourne, Vic, Australia; [Horakova, D.] Charles Univ Prague, Prague, Czech Republic; [Horakova, D.] Gen Univ Hosp, Prague, Czech Republic; [Zhen, Z.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Alroughani, R.] Amiri Hosp, Sharq, Kuwait; [Izquierdo, G.; Eichau, S.] Hosp Univ Virgen Macarena, Seville, Spain; [Kuhle, J.] Univ Hosp, Basel, Switzerland; [Kuhle, J.] Univ Basel, Basel, Switzerland; [Patti, F.] Univ Catania, Catania, Italy; [Grand'Maison, F.] Neuro Rive Sud, Longueuil, PQ, Canada; [Hodgkinson, S.] Liverpool Hosp, Sydney, NSW, Australia; [Grammond, P.] CISSS Chaudiere Appalache, Levis, PQ, Canada; [Lechner-Scott, J.] Univ Newcastle, Newcastle, NSW, Australia; [Butler, E.] Monash Med Ctr, Melbourne, Australia; [Prat, A.; Girard, M.; Duquette, P.] CHUM MS Ctr, Montreal, PQ, Canada; [Prat, A.; Girard, M.; Duquette, P.] Univ Montreal, Montreal, PQ, Canada; [Macdonell, R.] Austin Hlth, Melbourne, Australia; [Weinstock-Guttman, B.] Buffalo Gen Med Ctr, Buffalo, NY USA; [Ozakbas, S.] Dokuz Eylul Univ, Konak, Turkey; [Slee, M.] Flinders Univ S Australia, Adelaide, SA, Australia; [Sa, M. Jose] Ctr Hosp Univ Sao Joao, Porto, Portugal; [Van Pesch, V.] Clin Univ St Luc, Brussels, Belgium; [Barnett, M.] Brain & Mind Ctr, Sydney, NSW, Australia; [Van Wijmeersch, B.] Rehabil & MS Ctr Overpelt, Hasselt, Belgium; [Van Wijmeersch, B.] Hasselt Univ, Hasselt, Belgium; [Gerlach, O.] Zuyderland Med Ctr, Sittard Geleen, Netherlands; [Prevost, J.] CSSS St Jerome, St Jerome, PQ, Canada; [Terzi, M.] 19 Mayis Univ, Samsun, Turkey; [Boz, C.] KTU, Med Fac, Farabi Hosp, Trabzon, Turkey; [Laureys, G.; Van Hijfte, L.] Univ Hosp Ghent, Ghent, Belgium; [Kermode, A.] Univ Western Australia, Nedlands, WA, Australia; [Garber, J.] Westmead Hosp, Sydney, NSW, Australia; [Yamout, B.; Khoury, S. J.] Amer Univ, Beirut Med Ctr, Beirut, Lebanon; [Butzkueven, H.] MSBase Fdn, Melbourne, Australiaen_US
dc.descriptionKermode, Allan/0000-0002-4476-4016;en_US
dc.description.woscitationindexScience Citation Index Expanded - Conference Proceedings Citation Index - Science
dc.identifier.endpage647en_US
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.scopusqualityQ1
dc.identifier.startpage645en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/41084
dc.identifier.volume28en_US
dc.identifier.wosWOS:000866540802331
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherSage Publications Ltden_US
dc.relation.ispartofMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEfficacy and Persistence Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessationen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu